Constipation resident survival guide: Difference between revisions
No edit summary |
No edit summary |
||
Line 56: | Line 56: | ||
==Management== | ==Management== | ||
Shown below is an algorithm depicting the | ===Diagnostic Approach=== | ||
Shown below is an algorithm depicting the diagnostic approach of [[constipation]] in adults based on the [[American Gastroenterological Association]] (AGA) guideline.<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="Bharucha-2013">{{Cite journal | last1 = Bharucha | first1 = AE. | last2 = Dorn | first2 = SD. | last3 = Lembo | first3 = A. | last4 = Pressman | first4 = A. | title = American Gastroenterological Association medical position statement on constipation. | journal = Gastroenterology | volume = 144 | issue = 1 | pages = 211-7 | month = Jan | year = 2013 | doi = 10.1053/j.gastro.2012.10.029 | PMID = 23261064 }}</ref> | |||
{{Family tree/start}} | {{Family tree/start}} | ||
Line 146: | Line 145: | ||
{{familytree/end}} | {{familytree/end}} | ||
=== | ==Therapeutic Approach== | ||
Shown below are algorithms depicting the therapeutic approaches of clinical subgroups of [[constipation]] in adults based on the [[American Gastroenterological Association]] (AGA) guideline.<ref name="pmid23261065">{{cite journal| author=Bharucha AE, Pemberton JH, Locke GR| title=American Gastroenterological Association technical review on constipation. | journal=Gastroenterology | year= 2013 | volume= 144 | issue= 1 | pages= 218-38 | pmid=23261065 | doi=10.1053/j.gastro.2012.10.028 | pmc=PMC3531555 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23261065 }} </ref><ref name="Bharucha-2013">{{Cite journal | last1 = Bharucha | first1 = AE. | last2 = Dorn | first2 = SD. | last3 = Lembo | first3 = A. | last4 = Pressman | first4 = A. | title = American Gastroenterological Association medical position statement on constipation. | journal = Gastroenterology | volume = 144 | issue = 1 | pages = 211-7 | month = Jan | year = 2013 | doi = 10.1053/j.gastro.2012.10.029 | PMID = 23261064 }}</ref> | |||
===Refractory Constipation=== | |||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | }} | ||
Line 164: | Line 166: | ||
{{familytree/end}} | {{familytree/end}} | ||
=== | ===Normal Transit Constipation=== | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
Line 208: | Line 210: | ||
{{familytree/end}} | {{familytree/end}} | ||
=== | ===Slow Transit Constipation=== | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
Line 257: | Line 259: | ||
{{familytree/end}} | {{familytree/end}} | ||
=== | ===Pelvic Floor Dysfunction=== | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
Line 318: | Line 320: | ||
{{familytree/end}} | {{familytree/end}} | ||
=== | ===Combined Pelvic Floor Dysfunction and Slow Transit Constipation=== | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} |
Revision as of 20:19, 16 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Definition
Constipation is a syndrome that is characterized by difficulty in passing stool, by infrequent bowel movements, by hard stool, or by a feeling of incomplete evacuation that occurs either in isolation or secondary to another underlying disorder.[1][2][3]
Rome III criteria[1][4] | Pharmacologic studies based criteria[1][5] |
---|---|
Symptoms for ≥6 months and ≥2 of the following for the past 3 months: ● Straining during defecation |
Spontaneous bowel movements <3 per week and ≥1 of the following for at least 12 weeks during the past 12 months:
● Straining during more than one-fourth of defecation |
Clinical subgroups | Definitions |
---|---|
Normal transit constipation | Normal transit constipation refers to constipation in patients with normal anorectal function and normal colonic transit, with or without abnormal colonic motor disturbances and abnormal (ie, reduced or increased) colonic sensations. |
Slow transit constipation | Slow transit constipation refers to constipation in patients with normal anorectal function but slow colonic transit, with or without abnormal colonic motor disturbances and abnormal (ie, reduced or increased) colonic sensations. |
Defecatory disorders (Outlet obstruction, obstructed defecation, dyschezia, anismus, or pelvic floor dyssynergia) |
Defecatory disorders refer to constipation in patients with impaired rectal evacuation from inadequate rectal propulsive forces and/or increased resistance to evacuation during defecation, with or without structural disturbances like rectocele and intussusception, reduced rectal sensation, and slow colonic transit. Increased resistance to evacuation might follow high anal resting pressure (anismus) and/or incomplete relaxation or paradoxical contraction of the pelvic floor and external anal sphincters (dyssynergia). |
Combination disorders | Combination disorders refer to patients with combination or overlap of disorders (eg, STC with defecatory disorders), perhaps even an association with features of irritable bowel syndrome. |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Atropine poisoning
- Hypokalemia
- Lead poisoning
- Opium poisoning
- Severe dehydration
- Spinal cord injury
- Superior mesenteric artery occlusion
Common Causes
- Hardening of the feces: Improper mastication, low dietary fiber, dehydration and medications (aluminium, calcium, diuretic, iron).
- Paralysis or slowed transit: Hypothyroidism, hypokalemia, injured anal sphincter, medications (loperamide, codeine, morphine, tricyclic antidepressants) and severe systemic illness due to other causes.
- Constriction, where part of the intestine or rectum is narrowed or blocked: Diverticulosis, pelvic masses and stenosis.
- Psychosomatic constipation: Functional constipation and irritable bowel syndrome.[6]
- Smoking cessation[7]
- Abdominal surgery and childbirth
Management
Diagnostic Approach
Shown below is an algorithm depicting the diagnostic approach of constipation in adults based on the American Gastroenterological Association (AGA) guideline.[1][8]
Characterize the symptom: ❑ Any desire to defecate but an inability to pass a stool Associated symptoms: ❑ Abdominal pain or abdominal discomfort:
❑ Abdominal distention Obtain a detailed history: ❑ Dietary history: Dietary pattern change, low fiber diet, food intolerance, dehydration etc | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ General status: Pulse, blood pressure, respiratory rate, weight, thyroid
❑ Abdominal examination: Mass, distension, tenderness and bowel sounds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order tests: ❑ Complete blood count (CBC) When secondary causes are suspected: ❑ Colonoscopy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Possible etiologies after initial evaluation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Irritable bowel syndrome(IBS) | Unknown etiology | Organic constipation (mechanical obstruction or drug side effect) | Constipation secondary to systemic disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rx for IBS | Dietary fiber supplementation and simple laxatives | Treat the underlying etiology | Treat the underlying systemic disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refractory constipation if there is no response to initial management | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Therapeutic Approach
Shown below are algorithms depicting the therapeutic approaches of clinical subgroups of constipation in adults based on the American Gastroenterological Association (AGA) guideline.[1][8]
Refractory Constipation
Chronic constipation who have not responded to a high-fiber diet and/or over-the-counter laxatives after organic disorders have been excluded | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal BET, ARM, BD, CTT | Abnormal CTT Normal BET, ARM, BD | Abnormal BET, ARM, BD Normal CTT | Abnormal BET, ARM, BD, CTT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal transit constipation | Slow transit constipation | Pelvic floor dysfunction | Combined slow transit constipation and pelvic floor dysfunction | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal Transit Constipation
Normal transit constipation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiber ❑ Psyllium: 1 tsp up to 3 times daily PLUS Saline laxative ❑ Milk of magnesia: 15-30 ml OD or BID | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the same regimen | Adjust and change medications periodically | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Slow Transit Constipation
Slow transit constipation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiber ❑ Psyllium: 1 tsp up to 3 times daily PLUS Saline laxative ❑ Milk of magnesia: 15-30 ml OD or BID PLUS Stimulant laxative ❑ Bisacodyl: 10 mg suppositories or 5-10 mg orally up to 3 times/wk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continue the initial therapeutic regimen ❑ Fiber ❑ milk of magnesia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repeat colonic transit test with medications | Continue the initial therapeutic regimen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Delayed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjust medications as needed | Repeat BET and BD | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider illeo rectal anastamosis or subtotal colectomy | Manage for pelvic floor dysfunction | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pelvic Floor Dysfunction
Pelvic floor dysfunction | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abnormal BET or BD ❑ Define rectoanal angle High resting pressure ❑ Rule out anal fissure first Abnormal reflex ❑ Absence of rectoanal inhibitory reflex | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiber ❑ Psyllium: 1 tsp up to 3 times daily PLUS Stimulant laxative ❑ Bisacodyl: 10 mg suppositories or 5-10 mg orally up to 3 times/wk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biofeedback ❑ Anorectal and pelvic floor muscle activity are recorded by surface electromyographic sensors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Follow clinically | Repeat balloon expulsion test | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abnormal | Normal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform defecating proctogram | Manage as normal transit constipation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reassess biofeedback + medications if needed | Define anatomic rectal defect | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No response | Clinically significant | Insignificant | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider surgery | Surgical repair and follow up | No surgery needed | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Combined Pelvic Floor Dysfunction and Slow Transit Constipation
Combined pelvic floor dysfunction and slow transit constipation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biofeedback PLUS Dietary fiber: Psyllium/methylcellulose PLUS Stimulant laxative: Bisacodyl PLUS Saline laxative: Milk of magnesia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform colonic transit test without medications | Repeat balloon expulsion test | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If delayed manage as slow transit constipation | If normal follow clinically | Abnormal | Normal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform defecating proctogram | Manage as slow transit constipation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reassess biofeedback + add hyperosmolar agents (lactulose/PEG) | Define anatomic rectal defect | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No improvement | No response | Clinically significant | Insignificant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repeat colonic transit test on medications | Continue therapeutic regimen | Surgical repair and follow up | No surgery needed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Delayed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjust medications as needed | Consider surgery | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider surgery if no improvement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Do begin evaluation of constipation with a detailed history and physical examination that includes a rectal examination.
- Do perform a colonoscopy in patient's presenting with the recent onset of constipation without an obvious explanation, hematochezia, weight loss of ≥10 pounds, a family history of colon cancer or inflammatory bowel disease, anemia and positive fecal occult blood test.
- Do perform a trial of conservative management of lifestyle and dietary modification in patients without any of the above alarm symptoms.
Dont's
- Dont use insoluble fiber like wheat bran for the intial managment of constipation in adults.
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Bharucha AE, Pemberton JH, Locke GR (2013). "American Gastroenterological Association technical review on constipation". Gastroenterology. 144 (1): 218–38. doi:10.1053/j.gastro.2012.10.028. PMC 3531555. PMID 23261065.
- ↑ American College of Gastroenterology Chronic Constipation Task Force (2005). "An evidence-based approach to the management of chronic constipation in North America". Am J Gastroenterol. 100 Suppl 1: S1–4. doi:10.1111/j.1572-0241.2005.50613_1.x. PMID 16008640.
- ↑ Locke GR, Pemberton JH, Phillips SF (2000). "American Gastroenterological Association Medical Position Statement: guidelines on constipation". Gastroenterology. 119 (6): 1761–6. PMID 11113098.
- ↑ Longstreth, GF.; Thompson, WG.; Chey, WD.; Houghton, LA.; Mearin, F.; Spiller, RC. (2006). "Functional bowel disorders". Gastroenterology. 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561. Unknown parameter
|month=
ignored (help) - ↑ Lembo, AJ.; Kurtz, CB.; Macdougall, JE.; Lavins, BJ.; Currie, MG.; Fitch, DA.; Jeglinski, BI.; Johnston, JM. (2010). "Efficacy of linaclotide for patients with chronic constipation". Gastroenterology. 138 (3): 886–95.e1. doi:10.1053/j.gastro.2009.12.050. PMID 20045700. Unknown parameter
|month=
ignored (help) - ↑ Caldarella MP, Milano A, Laterza F; et al. (2005). "Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion". Am. J. Gastroenterol. 100 (2): 383–9. doi:10.1111/j.1572-0241.2005.40100.x. PMID 15667496.
- ↑ "Nicotine withdrawal symptoms:Constipation". helpwithsmoking.com. 2005. Retrieved 2007-06-29.
- ↑ 8.0 8.1 Bharucha, AE.; Dorn, SD.; Lembo, A.; Pressman, A. (2013). "American Gastroenterological Association medical position statement on constipation". Gastroenterology. 144 (1): 211–7. doi:10.1053/j.gastro.2012.10.029. PMID 23261064. Unknown parameter
|month=
ignored (help)